Economic Impact in Medicaid Beneficiaries with Schizophrenia and Cardiometabolic Comorbidities Treated with Once-Monthly Paliperidone Palmitate vs. Oral Atypical Antipsychotics

OBJECTIVE: The objective of this study was to compare persistence, costs, and healthcare resource utilization in patients with schizophrenia and cardiometabolic comorbidities treated with once-monthly paliperidone palmitate or an oral atypical antipsychotic. METHODS: Medicaid data from six states (0...

Descripción completa

Detalles Bibliográficos
Autores principales: Lafeuille, Marie-Hélène, Tandon, Neeta, Tiggelaar, Sean, Kamstra, Rhiannon, Lefebvre, Patrick, Kim, Edward, Yue, Yong, Joshi, Kruti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825393/
https://www.ncbi.nlm.nih.gov/pubmed/29363022
http://dx.doi.org/10.1007/s40801-018-0130-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825393/
https://www.ncbi.nlm.nih.gov/pubmed/29363022
http://dx.doi.org/10.1007/s40801-018-0130-4

Ejemplares similares